Annual Cash & Cash Equivalents
$1.47 M
-$2.32 M-61.25%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual cash & cash equivalents is $1.47 million, with the most recent change of -$2.32 million (-61.25%) on December 31, 2023.
- During the last 3 years, COEP annual cash & cash equivalents has risen by +$1.27 million (+623.69%).
- COEP annual cash & cash equivalents is now -61.25% below its all-time high of $3.79 million, reached on December 31, 2022.
Performance
COEP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.14 M
-$417.60 K-26.85%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly cash and cash equivalents is $1.14 million, with the most recent change of -$417.60 thousand (-26.85%) on September 1, 2024.
- Over the past year, COEP quarterly cash and cash equivalents has dropped by -$331.60 thousand (-22.57%).
- COEP quarterly cash and cash equivalents is now -84.57% below its all-time high of $7.37 million, reached on September 30, 2022.
Performance
COEP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COEP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.3% | -22.6% |
| 3 y3 years | +623.7% | -52.2% |
| 5 y5 years | +623.7% | -52.2% |
COEP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.3% | at low | -84.6% | +10.5% |
| 5 y | 5-year | -61.3% | +623.7% | -84.6% | +10.5% |
| alltime | all time | -61.3% | +623.7% | -84.6% | +10.5% |
Coeptis Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.14 M(-26.9%) |
| Jun 2024 | - | $1.56 M(+51.1%) |
| Mar 2024 | - | $1.03 M(-29.9%) |
| Dec 2023 | $1.47 M(-61.3%) | $1.47 M(+4.1%) |
| Sep 2023 | - | $1.41 M(-56.5%) |
| Jun 2023 | - | $3.24 M(+54.0%) |
| Mar 2023 | - | $2.11 M(-44.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.79 M(+73.9%) | $3.79 M(-48.6%) |
| Sep 2022 | - | $7.37 M(+209.9%) |
| Jun 2022 | - | $2.38 M(+1.5%) |
| Mar 2022 | - | $2.34 M(+7.5%) |
| Dec 2021 | $2.18 M(+973.7%) | - |
| Dec 2021 | - | $2.18 M |
| Dec 2020 | $203.00 K | - |
FAQ
- What is Coeptis Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual cash & cash equivalents year-on-year change?
- What is Coeptis Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Coeptis Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of COEP is $1.47 M
What is the all time high annual cash & cash equivalents for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual cash & cash equivalents is $3.79 M
What is Coeptis Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, COEP annual cash & cash equivalents has changed by -$2.32 M (-61.25%)
What is Coeptis Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of COEP is $1.14 M
What is the all time high quarterly cash and cash equivalents for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly cash and cash equivalents is $7.37 M
What is Coeptis Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, COEP quarterly cash and cash equivalents has changed by -$331.60 K (-22.57%)